Articles in Press [19 articles]

• PPAR? expression and function in mycobacterial infection: Roles in lipid metabolism, immunity and bacterial killing, Patricia Almeida, Alan Carneiro, Adriana Silva, and Patricia Torres Bozza
• PPARγ Signaling Mediates the Evolution, Development, Homeostasis and Repair of the Lung, Virender Rehan and J. Torday
• Prenatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Adult Metabolic Phenotype, Hernan Sierra, Reiko Sakurai, Wai-Nang Lee, Nghia Truong, J. Torday, and Virender Rehan
• PPAR? as a potential target to treat airway mucus hypersecretion in chronic airway inflammatory diseases, Yong-chun Shen, Lei Chen, Tao Wang, and Fu-qiang Wen
• Peroxisome Proliferator-Activated Receptor ? Plays an Important Role in the Expression of Monocyte Chemoattractant Protein-1 and Neointimal Hyperplasia after Vascular Injury, Yu Peng, Qiang Li, Lu Zhang, Ming Bai, and Zheng Zhang
• THE EFFECT OF PPAR AGONISTS ON THE MIGRATION OF MATURE AND IMMATURE EOSINOPHILS, Steven Smith, Haruki Imaoka, Neha Punia, Anam Irshad, L. Janssen, Roma Sehmi, and Gail Gauvreau
• Fenofibrate inhibited the differentiation of T helper 17 cells in vitro, Zhou Zhou, Weiliang Sun, Ying Liang, Yanxiang Gao, Wei Kong, Youfei Guan, Juan Feng, and Xian Wang
• Idealized PPARg-based therapies: lessons from bench and bedside, Angelica Amato and Francisco Neves
• The Nitrated Fatty Acid 10-Nitro-oleate Diminishes Severity of LPS-induced Acute Lung Injury in Mice, Aravind Reddy, Sowmya Lakshmi, and Raju C. Reddy
• PPARG epigenetic deregulation and its role in colorectal tumorigenesis, Alessandra Fucci, Lina Sabatino, Massimo Pancione, and Vittorio Colantuoni
• Nutraceuticals as Ligands of PPAR gamma, Meera Penumetcha and Nalini Santanam
• PPARd Survives Pancreatic ß-cells from Palmitate-induced Endoplasmic Reticulum Stress by Enhancing Fatty Acid Oxidation, Mingming Cao, Yuzhen Tong, Qinguo Lv, Xiang Chen, Yang Long, Li Jiang, Jun Wan, and Nanwei Tong
• Emerging PPARgamma–independent role of PPARgamma ligands in lung diseases., Ajit A. Kulkarni, Collynn F. Woeller, Thomas H. Thatcher, Sesquile Ramon, Richard P. Phipps, and Patricia J. Sime
• PPAR Medicines and Human Disease: The ABCs of it all, Anthony Apostoli and Christopher J. Nicol
• PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORa (PPARa) AGONISTS DIFFERENTIALLY REGULATE INHIBITOR OF DNA BINDING (ID2) EXPRESSION IN RODENTS AND HUMAN CELLS, María del Carmen González, J. Christopher Corton, Nuria Acero, Dolores Muñoz-Mingarro, Yolanda Quirós, Juan José Álvarez-Millán, Emilio Herrera, and Carlos Bocos
• Protection from metabolic dysregulation, obesity and atherosclerosis by citrus flavonoids: Activation of hepatic PGC1a-mediated fatty acid oxidation, Erin E Mulvihill and Murray W. Huff
• The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists, Tamotsu Tsukahara
• Plasticizers May Activate Human Hepatic Peroxisome Proliferator-Activated Receptor a Less Than That of a Mouse But May Activate Constitutive Androstane Receptor in liver, Yuki Ito, Toshiki Nakamura, Yukie Yanagiba, Doni Hikmat Ramdhan, Nozomi Yamagishi, Hisao Naito, Michihiro Kamijima, F. J. Gonzalez, and Tamie Nakajima
• The key to unlocking the chemotherapeutic potential of PPARγ ligands: Having the right combination, Graham Skelhorne-Gross and Christopher J. Nicol